Find Academic Supervisors

• Neurodegeneration
• Parkinson's Disease
• Mitochondrial Biology
• +5 more

Tony Schapira is Professor of Neurological Science at University College London (UCL) and Head of the Department of Clinical Neurosciences at UCL Institute of Neurology. He serves as a Consultant Neurologist at the National Hospital for Neurology and Neurosurgery and Royal Free Hospital, and holds additional leadership positions as Vice Dean of UCL Medical School and Director of the Royal Free Campus. His academic appointments include Visiting Professorships at Harvard (2009) and Yale (2010). Education includes: Bachelor of Science (Honours) from King's College London (1976) Bachelor of Medicine/Bachelor of Surgery from Charing Cross and Westminster Medical School (1979) Member of the Royal College of Physicians (1982) His primary research investigates neurodegeneration mechanisms in Parkinson's disease (PD), with emphasis on mitochondrial dysfunction, alpha-synuclein pathology, and GBA1 mutation pathways. His work spans molecular pathogenesis, drug development for disease modification, and clinical phenotyping of at-risk populations. Current projects focus on identifying prodromal biomarkers and developing neuroprotective therapies through international clinical trials. Schapira's recent publications (2024-2025) demonstrate concentrated research in Parkinson's disease mechanisms, mitochondrial biology, genetic risk factors (particularly GBA1 variants), and novel therapeutic approaches. Article themes consistently explore protein aggregation pathways, lysosomal function, metabolic interactions, and clinical trial methodologies. Awards and honors include: Fellow of the Academy of Medical Sciences (1999) Undergraduate Scholarship at Westminster Medical School He has supervised 11 PhD students and one MD candidate, and currently mentors post-graduate and post-doctoral researchers. His department received UCL's 'Excellence in Medical Education' award (2007-2008). Major grants include co-principal investigator roles on: MRC-Wellcome Strategic Award in Neurodegeneration (£6 million) Wolfson Award (£20 million) He directs a research department comprising 3 Readers, a Senior Lecturer, technicians, and academic staff, with facilities for biochemistry, molecular biology, tissue culture, and advanced imaging. The team investigates neurodegenerative disorders including Parkinson's, Huntington's, and Friedreich's ataxia.

Mark FarmanView profile

Professor

• Fungal Pathogenesis
• Genomics
• Molecular Biology
• +3 more

Mark Farman is a Professor at the University of Kentucky, affiliated with the Martin-Gatton College of Agriculture, Food and Environment and the Department of Plant Pathology. He serves as Director of the Advanced Genetic Technologies Center and leads the Farman Lab. Research Focus: The Farman Lab investigates fungal pathogenesis mechanisms in Magnaporthe oryzae , emphasizing fungal genome evolution, telomere roles in pathogenic variation, and high-throughput protein localization during host infection. Teaching: Courses include PPA 600 (Critical Methods in Plant-Microbe Interactions), PPA 500 (Physiology of Plant Health and Disease) as guest lecturer, and PPA 784 (Special Problems in Plant Pathology). Educational Background: PhD in Molecular Biology (1990) and BS in Biology (1983) from the University of East Anglia, UK. Basil O'Connor Starter Scholar Award (1999)

Linda NiedzielaView profile

Associate Professor

• Genetics
• Toxicology
• Molecular Genetics
• +3 more

Linda Niedziela is an Associate Professor of Biology and Chair of the Department of Biology at Elon University, where she has served since 2000 after positions at the University of Richmond and North Carolina A&T State University. Her research integrates molecular genetics with environmental toxicology to investigate contaminant effects on biological systems. Education: Ph.D. in Genetics and Developmental Biology, West Virginia University (1987) B.S. in Pre-Professional Biology, University of Pittsburgh, Johnstown (1984) Research Interests: Dr. Niedziela specializes in genetic toxicology and environmental contaminant impacts, utilizing zebrafish and brine shrimp models to study developmental neurotoxicology, mutagenesis, and pollutant effects. Her work bridges molecular mechanisms with ecological health, emphasizing undergraduate research training in toxicological methodologies and biotechnology applications. Publication Trends: Her 9 publications (1986-2009) demonstrate an evolution from foundational genotoxicity assays (micronucleus, sister chromatid exchange) using mammalian models to applied aquatic toxicology with zebrafish, alongside educational innovations in bioinformatics. Recurring themes include chemical risk assessment of environmental pollutants and pedagogical development for science education. Scientific Awards: Historically Minority University Biotechnology Program Initiative Service Award (2002) FANS - Faculty Assisting New Students (2004) Pan-Hellenic Excellence in Teaching Recognition (2005) Rawl’s Professor for Undergraduate Research in the Sciences (2007-2010) Elon College Excellence in Teaching Award (2011) Advising and Grants: She has mentored 17+ undergraduate researchers through co-authored conference presentations and guided over a dozen Elon College Fellows. Her $244,733 in secured funding includes 9 grants from the North Carolina Biotechnology Center and Elon University for establishing zebrafish models, enhancing molecular biology infrastructure, and investigating oil dispersant toxicity, demonstrating strong support for her research program. Labs and Teams: Dr. Niedziela directs a toxicology research laboratory featuring specialized aquatic habitats for zebrafish studies and collaborates with the Elon College Fellows program as Mathematics/National Science Branch Director, shaping interdisciplinary science education while advancing campus-wide undergraduate research initiatives.

• Infectious Disease Modeling
• Vector-Borne Disease Epidemiology
• Mathematical Forecasting
• +4 more

Michael Johansson serves as a Research Professor at Northeastern University's Roux Institute, maintaining offices in London, UK and Portland, ME. His work bridges public health research and operational response through advanced statistical and mathematical modeling of infectious diseases, with primary focus on vector-borne pathogens including dengue, Zika, chikungunya, and West Nile virus. Previously with the CDC in Puerto Rico for over a decade, he co-founded the Epidemic Prediction Initiative and led modeling efforts during Zika, COVID-19, and dengue emergencies. His research integrates biological, ecological, climatic, socioeconomic, and behavioral factors to understand disease emergence and transmission dynamics. Key methodologies include network-based forecasting models, climate-disease interaction analysis, and development of early warning systems. Current work emphasizes improving surveillance, burden estimation, and control strategy evaluation for arboviral diseases through quantitative tools. Recent publications demonstrate expertise in dengue synchronization across the Americas, West Nile virus forecasting, and addressing biases in mobility data for outbreak modeling. His work spans from molecular-level antibody response analysis to global risk mapping, consistently emphasizing operational implementation of research findings. Johansson actively contributes to public health practice through conference presentations including the 2025 American Mosquito Control Association Annual Meeting. His modeling frameworks have directly informed CDC emergency responses and the development of collaborative forecasting initiatives that pioneer open, transparent disease prediction.

Franco MazzeiView profile

Professor

• Electrochemical biosensors
• Optical biosensors
• Nanotechnology
• +6 more

Franco Mazzei is a Full Professor at the Department of Chemistry and Pharmacy Technology , Sapienza University of Rome . He leads the Biosensors Laboratory and specializes in electrochemical and optical biosensors for clinical, food, and environmental applications. Research Interests Development of electrochemical biosensors using voltammetric, amperometric, and impedimetric techniques Optical biosensors based on surface plasmon resonance (SPR) and Raman spectroscopy Application of supramolecular chemistry for protein immobilization Study of nanostructured materials and conductive polymers in sensor development Collaborative projects with the Ministry of Health and EU initiatives (6th Framework Programme, Eurostars) Notable Publications focus on: SPR immunosensors for doping agent detection Gold nanoparticle-based platforms for biofuel cells and H2O2 sensing Supramolecular strategies for antibody immobilization and mycotoxin detection Advanced materials like lignin nanoparticles and polythiophene composites Environmental applications including PFAS monitoring and COD analysis Laboratory Activities include the use of: PGSTAT204 Electrochemical Interface for sensor development Spectroelectrochemical Raman for surface analysis Surface Plasmon Resonance (SPR) systems for biomolecular interactions QCM (Quartz Crystal Microbalance) for immunosensor validation

• Microfluidics
• Point-of-care diagnostics
• Antibiotic susceptibility testing
• +4 more

Dr. Al Edwards is a Professor in the Department of Pharmacy within the School of Chemistry, Food and Pharmacy at the University of Reading. His extensive research portfolio spans over two decades, with a clear evolution from immunology and dendritic cell biology in his earlier career to his current focus on microfluidic diagnostic devices and point-of-care testing technologies. Professor Edwards' research interests center on developing innovative diagnostic solutions, particularly in microfluidics and point-of-care testing. His work bridges engineering and clinical applications, with significant contributions to antibiotic susceptibility testing, vaccine delivery systems, and smartphone-based diagnostic platforms. His research has evolved from fundamental immunological studies to highly applied diagnostic device development, demonstrating a strong translational research trajectory. His publication record shows a clear trend toward practical diagnostic solutions with clinical applications, particularly in antibiotic susceptibility testing and point-of-care diagnostics. The integration of microfluidics, 3D printing, and smartphone technology represents the cutting edge of his current research, with numerous publications demonstrating how these technologies can be combined to create accessible diagnostic tools for resource-limited settings. Professor Edwards has been actively involved in mentoring researchers and collaborating across disciplines, as evidenced by his numerous co-authored publications. His work on diagnostic device usability and information design for self-testing demonstrates attention to the practical implementation challenges of diagnostic technologies. His laboratory appears to specialize in developing open-source, low-cost diagnostic platforms using Raspberry Pi systems, 3D printing, and microcapillary technologies. The Cygnus platform for smartphone-based diagnostics and the PiRamid imaging system represent significant contributions to making sophisticated diagnostic technologies more accessible.

• Structural Biology
• X-ray Crystallography
• Protein-Ligand Interactions
• +3 more

Prof. Dr. Renu Batra-Safferling is a structural biology researcher at the Institute of Plant Biochemistry (IPB) within the Faculty of Mathematics and Natural Sciences at Heinrich Heine University Düsseldorf . Her work focuses on protein structure-function relationships through X-ray crystallography and biophysical analysis, particularly in signaling components of visual transduction pathways and LOV-family blue-light photoreceptors. Research Areas: Structural biology of signaling proteins, protein-ligand interactions, photoreceptor dynamics, and natively unfolded protein characterization. Techniques: X-ray crystallography, site-directed mutagenesis, transient/steady-state kinetics, dynamic light scattering, and CD spectroscopy. Her recent publications investigate phospholipase A mechanisms in Pseudomonas aeruginosa , LOV protein dark recovery kinetics, chemokine CCL16 dynamics, and arrestin activation via phosphorylated peptides. Collaborative work spans enzymology, photoreceptor biophysics, and protein aggregation studies. Students: Master student Lisa Jungbluth and Bachelor student Leon Hennecke Email: r.batra-safferling@fz-juelich.de

Thomas ManningView profile

Professor

• Cancer Drug Development
• Infectious Disease Drug Development
• Neurological Drug Development
• +2 more

Dr. Thomas Manning is a Professor at Valdosta State University teaching Instrumental Analysis, Environmental Chemistry, Physical Chemistry, and marine-related courses. His research bridges pharmaceutical innovation and marine ecosystem restoration, with significant contributions to drug development for cancer, infectious diseases, and neurological disorders. Education: B.S. in Chemistry, College of Charleston M.S. in Chemistry, University of Florida Ph.D. in Chemistry, University of Florida His primary research focuses on metal-based drug complexes, yielding 20 pre-clinical candidates at the National Cancer Institute, a patented multidrug-resistant tuberculosis treatment, and novel COVID-19 therapies. Concurrently, he leads oyster and coral restoration projects applying chemical defense systems and nutrient substrates to marine rehabilitation. His work integrates medicinal chemistry with environmental science to address therapeutic and ecological challenges. Recent publications (2025-2016) reveal consistent themes: copper/iron complexes enhancing drug efficacy against cancer and infections (e.g., paclitaxel-copper crystals, isoniazid repurposing), inhalation therapies for tuberculosis/COVID-19, and microbial-nutrient systems for marine restoration. These span pharmaceutical chemistry, virology, and marine ecology, demonstrating translational applications from antiviral agents to coral reef rehabilitation. Dr. Manning mentors undergraduate researchers in his lab, producing patented drugs and pre-clinical candidates through National Cancer Institute collaborations. His marine restoration projects involve field implementation of microbial coatings and mineral substrates for oyster/coral rehabilitation, supported by university resources and interdisciplinary partnerships. Based in Bailey Science Building #3076, his research group leverages university facilities for drug synthesis and marine ecosystem studies, maintaining active projects in pharmaceutical development and coastal habitat restoration through undergraduate-driven innovation.

Renu JohnView profile

Professor

• Biomedical Imaging
• Optical Coherence Tomography
• Nanoparticles
• +8 more

Renu John is a Professor in the Department of Biomedical Engineering at Indian Institute of Technology Hyderabad . He earned his Ph.D. in Physics (Optics) from IIT Delhi in 2006 and has held postdoctoral positions at Duke University and University of Illinois . He leads the Medical Optics and Sensors Laboratory (MOS) and co-founded the Center for Healthcare Entrepreneurship (CfHE) , focusing on affordable healthcare solutions for India. Research Interests : Biomedical Imaging, Optical Coherence Tomography (OCT), Digital Holography, AI/ML in Diagnostics, Microfluidic Biosensors, 3D Bioprinting, Nanoparticle-based Imaging, Optical Elastography. Awards : Best Paper & Poster Awards at international conferences (2018-2019), Samsung Innovation Award (2018) for smartphone-based oral cancer detection. Grants : Lead investigator for an ICMR Center of Excellence (15.2 Cr funding) in Medical Devices and Diagnostics. Students : Mentored over 20 researchers, including current and alumni Ph.D. candidates working on OCT, microfluidics, AI-driven imaging, and biosensor development. Labs & Innovations : The MOS Lab develops cutting-edge technologies like lensless microscopes, FF-OCT systems, and dual-modality biosensors. His team has filed 18 patents and published 117 international journal articles, with projects spanning from in vivo magnetomotive imaging to organ-on-chip platforms for disease modeling.

Heinrich JungView profile

Professor

• Microbiology
• Membrane Protein Structure and Function
• Transport
• +4 more

Prof. Dr. Heinrich Jung is a faculty member at the Department of Microbiology, Faculty of Biology, Ludwig Maximilian University of Munich. His research focuses on membrane protein structure-function relationships, particularly sodium-coupled transporters like PutP and CaiT in prokaryotes. Specializes in Microbiology and Membrane Protein Dynamics Utilizes crystallography , EPR spectroscopy , and functional assays Investigates transport mechanisms in pathogens like Helicobacter pylori Research trends in recent publications highlight: Elucidating efflux systems (e.g., ParXY, TtgABC) and their roles in bacterial resistance Structural and functional analysis of solute/sodium symporters and antiporters Exploration of two-component regulatory systems (MxtR/ErdR) in carbon metabolism Biophysical studies on transmembrane domain dynamics using DEER spectroscopy

Sebastian SuerbaumView profile

Professor

• Medical Microbiology
• Infectious Diseases
• Gastrointestinal Infections
• +6 more

Prof. Dr. med. Sebastian Suerbaum is Professor and Chairman of Medical Microbiology and Hospital Epidemiology at the Max von Pettenkofer Institute, Faculty of Medicine, Ludwig-Maximilians-Universität (LMU) Munich. A physician-scientist trained in internal medicine and medical microbiology, he leads a research group that integrates experimental microbiology with comparative genomics to understand and combat gastrointestinal infections, in particular those caused by Helicobacter pylori and Campylobacter jejuni . Education & Training Medical School: Ruhr-Universität Bochum, Universität Wien, and Harvard Medical School MD thesis, Ruhr-Universität Bochum (1988) Clinical training in Internal Medicine, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg Specialty board certification in Medical Microbiology, Virology and Infection Epidemiology, Ruhr-Universität Bochum Post-doctoral fellowship, Institut Pasteur, Paris (1991–1993) Habilitation in Medical Microbiology Research Focus The Suerbaum laboratory combines in vivo models, human samples, high-throughput sequencing and bioinformatics to dissect bacterial adaptation during chronic infection. Central themes include the extreme genome plasticity and epigenetic methylation landscapes of Helicobacter pylori , the evolution of antibiotic resistance, the development of rapid culture-independent diagnostic workflows integrating endoscopy and molecular resistance testing, and the interplay between gastric/intestinal microbiota and disease outcomes such as gastric cancer and inflammatory bowel disease. Scientific Awards & Honours Gerhard Hess Award, Deutsche Forschungsgemeinschaft DGHM Main Award, German Society for Hygiene and Microbiology Eva and Klaus Grohe Award, Berlin-Brandenburg Academy of Sciences Elected Member: German National Academy of Sciences Leopoldina, American Academy of Microbiology, European Academy of Microbiology, Academia Europaea Leadership & Service Prof. Suerbaum served as President of the German Society for Hygiene and Microbiology (DGHM) 2010–2014 and currently chairs the Scientific Advisory Board of the Robert Koch Institute while also sitting on the Scientific Advisory Board of the Robert Koch Foundation. He is actively involved in national guideline committees (DGVS S2k guidelines on H. pylori and gastrointestinal infections) and directs structured doctoral programs at the Max von Pettenkofer Institute. Laboratory & Team The Research Group ‘Suerbaum’ is located in the Max von Pettenkofer Institute, Pettenkoferstraße 9a, 80336 München. The team includes post-doctoral researchers, PhD candidates and technical staff working in state-of-the-art BSL-2 facilities with access to clinical sample biobanks and next-generation sequencing platforms.

Fran AweekaView profile

Professor

• HIV Pharmacology
• Malaria Pharmacology
• Tuberculosis Pharmacology
• +6 more

Fran Aweeka is a Professor and Vice Chair of Research at the Department of Clinical Pharmacy, University of California San Francisco (UCSF) School of Pharmacy . She directs the Drug Research Unit (DRU) and serves as the Pharmacology Core Lead for the UCSF Center for AIDS Research . Her research focuses on pharmacokinetic and pharmacodynamic studies of HIV, malaria, and tuberculosis drugs, particularly in vulnerable populations in Africa and the U.S. She actively contributes to the PharmD degree program as a co-director of the Inquiry component and mentors students in pharmacology and international research. As a clinical pharmacologist with over 25 years of experience, Dr. Aweeka investigates drug interactions in co-infected patients, pharmacokinetics in pregnancy and pediatric populations, and mechanisms of HIV-associated inflammation. Her work includes PI roles on NIH R01 grants and leadership in global health initiatives like seasonal malaria chemoprevention studies in Uganda. The DRU under her direction provides advanced analytical techniques for drug quantification in plasma and target tissues, supporting over 30 NIH studies. Her recent research trends include pharmacokinetic-pharmacodynamic modeling of antimalarial and antiretroviral combinations, microvolume plasma assays , and drug exposure-response relationships in resource-limited settings. Publications from 2021–2025 reflect these areas, with emphasis on pregnancy pharmacokinetics , pediatric dosing , and global health pharmacology . Dr. Aweeka holds a PharmD from UCSF (1985) and a BS in Biological Sciences from USC (1981). She is a licensed pharmacist in California and has completed leadership programs like the Mentor Development Program . Her lab supports collaborative projects across national and international institutions, focusing on drug quantification in plasma, dried blood spots, and target cells.

• Nanomaterials
• Photophysics
• Sensor Development
• +6 more

Alice Sciortino is a Researcher at the Department of Physics and Chemistry - Emilio Segrè within the School of Science at the University of Palermo. Her position code PHYS-03/A indicates a research-focused academic track in the Italian university system. She maintains regular office hours on Tuesdays from 11:30 to 12:30 through the university's student portal system. Her research centers on advanced photonic nanomaterials with particular expertise in carbon nanodots , quantum dot superstructures , and metal-organic frameworks . Key research themes include: Nanoscale light emission and lasing phenomena Design of optical sensors for environmental and biomedical applications Photocatalytic systems for environmental remediation Hybrid nanomaterial interfaces for energy transfer Ultrafast photophysical characterization of nanomaterials Analysis of her recent publications (2023-2025) reveals a strong trajectory toward multifunctional nanoplatforms combining optical, magnetic, and catalytic properties. Her work increasingly bridges fundamental photophysics with practical applications in environmental monitoring and biomedicine, particularly in heavy metal detection (Hg²⁺, Ni²⁺) and tissue engineering. The publication record shows consistent high-output research with frequent collaborations across Italian institutions. While no formal scientific awards are documented in the provided materials, her extensive publication record in high-impact journals demonstrates significant scholarly contributions to nanophotonics and materials science. Dr. Sciortino's research program appears to focus on experimental nanomaterials development with strong emphasis on optical characterization techniques. Her work on carbon dot-MOF hybrids and quantum dot superparticles suggests leadership in designing next-generation photonic nanomaterials with tunable properties. The consistent funding evident from her publication output likely supports laboratory infrastructure for nanomaterials synthesis and advanced optical spectroscopy.

Damian KułagaView profile

Assistant Professor

• Medicinal Chemistry
• Organic Chemistry
• Computational Chemistry
• +4 more

Dr. Eng. Damian Kułaga is a Research and Teaching Assistant Professor at the Department of Organic Chemistry and Technology (C-2) , Faculty of Chemical Engineering and Technology, Tadeusz Kościuszko Cracow University of Technology. He obtained his M.Sc. in Light Organic Technology (2015) and Ph.D. in Chemical Engineering (2023) from the same institution, with postgraduate pedagogical studies completed in 2020. Education M.Sc. in Light Organic Technology, Cracow University of Technology (2015) Ph.D. in Chemical Engineering, Cracow University of Technology (2023) Postgraduate Pedagogical Studies, Cracow University of Technology (2020) Kułaga's research spans Medicinal Chemistry , Organic Synthesis , and Computational Drug Design , focusing on: Designing bioactive compounds for CNS disorders (depression, schizophrenia) and oncology (TNBC, CRC) Lead optimization for improved pharmacological parameters (ADME-T) Docking and molecular dynamics for structure-based drug design Green chemistry methods (microwave/sound-assisted solvent-free reactions) Synthesis of heterocycles and steroid bioconjugates His work has produced 15+ publications (2016–2025) on topics including: Anticancer triazine derivatives for colorectal cancer Dual-target ligands for Alzheimer’s and CNS diseases Ultrasound/microwave-assisted drug synthesis protocols 5-HT7 receptor agonists/antagonists for psychiatric and oncological applications Scientific Awards : GOLD MEDAL ARCA 2017 (Trazodone synthesis method) BRONZE AWARD KIWIE2017 (Aripiprazole synthesis) GOLD MEDAL IWIS2018 (solvent-free active substance synthesis) Multiple international medals (SILVER, HONORABLE MENTION) for CNS and oncology drug innovations First place poster award at X Medical Chemistry Symposium (2021) Grants & Projects : NCBiR LIDER grants for 5-HT7 receptor ligands in TNBC (2022–2025) and CNS ligands (2016–2019) Subwencja N+B grant for indolyl aminotriazines (2021–) FNP/Proof of Concept grant for DK-AT390HCI small-molecule anticancer agent (2024–2025) International Collaborations : Research stays at Sapienza Universita di Roma (Italy), Institute of Pharmacology PAN (Poland), and Experimental & Innovative Medicine Center UJ-UR (Poland)

Michael NizhnikovView profile

Associate Professor

• Behavioral Neuroscience
• Developmental Psychopharmacology
• Addiction Science
• +3 more

Michael Nizhnikov serves as Chairperson and Associate Professor in the Department of Psychology at Southern Connecticut State University, where he leads academic initiatives while maintaining an active research program in behavioral neuroscience. His institutional affiliation reflects deep integration within the university's academic structure, with primary responsibilities spanning departmental leadership and specialized instruction in psychological sciences. Dr. Nizhnikov's research program centers on the transgenerational and developmental neurobehavioral consequences of ethanol exposure, utilizing sophisticated rodent models to investigate critical questions across the lifespan. His work systematically examines how prenatal and early-life alcohol exposure alters behavioral phenotypes, with particular emphasis on transgenerational epigenetic mechanisms, stress interactions, and opioid system involvement in ethanol reinforcement. Key investigations span anxiety-like behaviors, ethanol consumption patterns, cognitive performance, and neurotoxic outcomes across developmental stages from infancy through adulthood, demonstrating rigorous methodological approaches including genetic strain comparisons and pharmacological interventions. Analysis of his 15 most recent publications (2015-2021) reveals a cohesive research trajectory focused on transgenerational transmission of ethanol effects, age-dependent neurobehavioral vulnerabilities, and reinforcement mechanisms. The predominant themes include paternal/maternal lineage contributions to fetal alcohol spectrum disorders, strain-specific programming effects, and critical interactions between stress and ethanol exposure across developmental windows. Methodologically, his work consistently employs rat models across infancy, adolescence, and adulthood to examine ethanol intake, anxiety responses, and cognitive performance using elevated plus maze, T-maze, and operant self-administration paradigms, with growing emphasis on kappa and mu opioid receptor mechanisms. No scientific awards were documented in the source materials. Information regarding student advising responsibilities, research grants, laboratory infrastructure, or collaborative teams was not provided in the available institutional profile or publication records.